...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith/Pfizer

any news as to wether this has started yet and any antisipsted time lines?

Share
New Message
Please login to post a reply